Lipids Flashcards
Classes of Lipids
-
Glycerolipids
- Triacylglycerols
- Phospholipids
-
Sphingolipids
- Sphingophospholipids
- Sphingoglycolipids
- Isoprenoids
- Eicosanoids

Phospholipids
- Major lipid component of cell membranes
- Composed of an alcohol attached via a phosphodiester bond to either:
-
Diacylglycerol (DAG) ⇒ glycerolphospholipid
- DAG is an intermediate of TAG synthesis
-
Ceramide ⇒ sphingophospholipid
- An amino alcohol spingosine with a fatty acid esterified to the amino group
-
Diacylglycerol (DAG) ⇒ glycerolphospholipid
Triacylglycerol Synthesis
- Glucose or glycerol used to synthesize glycerol-3-phosphate
- Fatty acid tails added via esterification to glycerol-3-phosphate to produce triacylglycerol.
- Phosphatidic acid (aka DAG-P) can be dephosphorylated to DAG then acylated to form TAG.

TAG Functions
- An intermediate for glycerolphospholipid synthesis
- Energy storage medium
- Structural component of lipoproteins
Glycerophospholipids
The major class of phospholipids.
Phosphatidic acid is the simplest glycerophospholipid.
All others are derived from it by esterification of an alcohol.

Cardiolipid
Two phosphatidic acids esterified to an additional glycerol molecule.
- Class of glycerophospholipids
- Found only in the inner mitochondrial membrane
- Required for functioning of the mitochondrial ETC

Plasmalogens
Glycerophospholipid where fatty acid at C-1 of glycerol is attached via an ether linkage.
- Most common plasmalogens are:
- Phosphatidalethanolamine
- Phosphatidalcholine
- -al suffix instead of -yl
- Almost 30% of glycerophospholipids in the brain are plasmologens
- Reduced levels of plasmologens associated with Alzheimer’s disease

Platelet-activating Factor
(PAF)
Ether glycerophospholipid with the fatty acid chain on C-2 replaced with an acetyl group.
- PAF is a mediator of many physiological processes including:
- Platelet aggregation and degranulation
- Inflammation
- Anaphylaxis
Head Groups
Various alcohols which can be esterified to phosphatidic acid:

Glycerophospholipid Charge
- Net charge on a glycerophospholipid depends upon the head group.
- Charge affects the nature of the membrane surface.

Glycerophospholipid
Acyl Tails
- Acyl tails can vary from lipid to lipid and cell type to cell type
- Acyl tails effect the ability to pack lipids and thus membrane fluidity:
- Inc length = dec fluidity
- Double bonds = inc fluidity
- Unsaturated FA usually at C-2
- Saturated FA usually at C-1
- Naturally occuring lipids have saturated or cis-DB
- Changing membrane fluidity effects:
- Transport
- Signal transduction
- Etc.

Sphingophospholipids
- Use the long chain amino alcohol sphingosine as a backbone to which FA are attached
- Ceramide is a sphingosine with an extra FA attached
- Major sphingophospholipid in humans is sphingomyelin
- Has a choline head group
- Sometimes ethanolamine found instead
- Sphingomyelin is a major component of the myelin sheath

Phosphatidic Acid Synthesis
- Glucose ⇒ DHAP ⇒ Glycerol-3-Phosphate
or
- Glycerol ⇒ Glycerol-3-Phosphate
- Two fatty acyl tails attached to glycerol-3-phosphate using fatty acyl CoA substrates
- Water esterified as phosphate headgroup to form phosphatidic acid

Phospholipid Synthesis
from
Phosphatidic Acid
- Phosphatidic acid is dephosphorylated to diacylglycerol (DAG)
- CDP is used to activate choline or ethanolamine.
- DAG is condensed with CDP-activated alcohols to form phospholipids.
- DAG + CDP-choline ⇒ Phosphatidylcholine (PC aka lecithin)
- DAG + CDP-ethanolamine ⇒ Phosphatidylethanolamine (PE)
OR
- Phosphatidic acid is dephosphorylated to diacylglycerol (DAG)
- DAG is activated by CDP forming CDP-DAG
- CDP-DAG is condensed with inositol to form Phosphatidylinositol (PI)
- CDP-DAG is condensed with glycerol to form Phosphatidylglycerol (PG)

Phospholipid Interconversion
PC can be made through methylation of PE using SAM.
PS can be made from PE through base exchange of ethanolamine for serine.

Glycerolphospholipid
Grand Scheme

Phospholipases
- Phospholipases hydrolyze phosphodiester bonds.
- Different phospholipases cleave specific phosphodiester bonds.
- Functions to:
- Degrade glycerolphospholipids
- Generate secondary messengers
- Release acyl chains which serve as intermediates in the synthesis of biologically-active molecules
- PL-A1 : cleaves at C-1 producing a lysolipid
-
PL-A2: cleaves at C-2 producing arachidonic acid
- serves as a precursor for eicosanoids
- Cortisol’s anti-inflammatory action via PL-A2 inhibition
-
PL-C: cleaves at ester bond on C-3
- can be activated by specific GPCR’s
- acts on PIP2 to produce DAG and IP3

Pulmonary Surfactant
- Type II pneumocytes synthesize and secrete dipalmitoyl PC (DPPC) which is the main component of surfactant.
- Surfactant prevents alveoli collapse during expiration and reduces pressure needed to inflate alveoli during inspiration.
- DPPC synthesis markedly increases around 32 weeks.
- Lack of surfactant main cause of infant respiratory distress syndrome (IRDS)
- An amniotic fluid lecithin-sphingomyelin (L/S) ratio > 2 indicative of sufficient surfactant synthesis
Synthesis of Plasmalogens
- Ether lipids synthesized from:
- DHAP
- Fatty acids
- Fatty alcohols
- Fatty acid esterified at C-1
- FA exchanged with a long chain fatty alcohol in peroxisomes
- Patients with Zellweger disease are unable to synthesize plasmalogens

Sphingomyelin Synthesis
-
Palmitoyl-CoA condensed with serine to produce sphinganine by Serine Palmitoyl Transferase.
- Reaction requires PLP and NADPH
- Second acyl tail is added from a fatty acyl-CoA to produce ceramide.
- Choline is transfered from PC to ceramide producing sphingomyelin.

Sphingomyelin Degradation
-
Sphingomyelinase (SMase) removes phosphorylcholine from sphingomyelin producing a ceramide.
- Several isoforms of SMase classified according to pH optima.
- Defects in lysosomal acid SMase leads to type A and B Niemann-Pick Disease
- Ceramide degraded into sphingosine and free fatty acid.
Niemann-Pick Disease
Caused by a deficiency of lysosomal acid SMase.
Autosomal recessive.
Results in build-up of sphingomyelin in liver, spleen, and CNS.
- Type A has < 1% enzyme activity.
- Extensive developmental disability
- Neurodegeneration
- Death in early childhood
- Type B has ~ 5-10% enzyme activity.
Glycosphingolipids
- Derived from ceramide
- Do not have a phosphoester moiety
- Polar portion provided by a monosaccharide or oligosaccharide attached via an O-glycosidic linkage
- Depending on number and type of sugar attached, glycosphingolipids subclassified as:
- neutral glycosphingolipids
- acidic glycosphingolipids

Acidic Glycosphingolipids
- Negatively charged at physiological pH due to the presence of:
- N-acetylneuraminic acid (NANA, a sialic acid) in gangliosides
- Sulfates in sulfatides
- Gangliosides
- Primarily found in ganglion cells of CNS
- Named based on number of NANA moieties attached
- Mono - GM series
- Di - GD series
- Tri - GT series
- Quarto - GQ series
- Carbohydrate moiety protrudes from cell surface
- Cell recognition
- Cell-cell communication
- “receptors” for bacterial toxins
- Cholera toxin interacts with GM1

Sulfatides
Cerebrosides containing sulfated galactosyl residues.

Glycosphingolipid Synthesis
- Sequential attachment of UDP-sugars by glycosyl transferases to glucose in glucocerebrosides.
- Occurs primarily in Golgi

Sulfatide Synthesis
- Ceramide condensed with UDP-galactose to produce a galactocerebroside.
- Sulfate groups attached to 3’ OH of galactose by sulfotransferase using PAPS as sulfate donor

Glycosphingolipid Degradation
- Glycosphingolipids internalized by endocytosis into lysosomes
- Sugars removed one at a time by family of lysosomal hydrolases producing ceramide
- If a hydrolase is absent or reduced, gluycosphingolipid will accumulate in lysosomes ⇒ lipidoses
- Ceramide degraded into sphingosine and free fatty acid
- Synthesis & degradation normally balanced so glycosphingolipid concentration in membranes relatively constant
Tay-Sachs Disease
- Caused by a defect in β-hexosaminidase A
- Leads to a build-up of GM2

Gaucher Disease
- Caused by a defect in β-glucosidase
- Leads to build-up of glucocerebrosides

Krabbe Disease
- Defect in β-galactosidase
- Results in accumulation of galactocerebrosides

Fabry Disease
- Defect in α-Galactosidase
- Accumulation of globosides

Eicosanoids
- Derived from 20-carbon unsaturated ω-6 fatty acids
- Most derived from arachidonic acid (20:45,8,11,14)
- Made from dietary linoleic acid
- Arachidonic acid released from membrane phospholipids by PL-A2
- Inhibited by cortisol
- Most derived from arachidonic acid (20:45,8,11,14)
Includes
-
Prostaglandins & Thromboxanes
- Act through G-protein coupled receptors
- Involved in inflammation
- Affect gastric acid and mucosal secretion
- Platelet aggregation
- Ovulation
- Control of blood vessel diameter
-
Leukotrienes
- Regulate neutrophil and eosinophil function
- Play a role in allergic response and airway diameter
Prostaglandins & Thromboxanes
Synthesis
-
Arachidonic acid converted to PGH2 by PGH Synthase, an enzyme with two catalytic activities.
- Arachidonic acid converted to PGG2 intermediate by fatty acid cyclooxygenase (COX) activity in an _O2-_requiring reaction
- PGG2 converted to PGH2 by peroxidase activity in a glutathione-requiring reaction
- PGH2 converted to a number of products depending on cell type:
- Endothelial cells ⇒ PGI2 (prostacyclin)
- Platelets ⇒ thromboxane A2 (TXA2)
- Other cells: PGF2 and PGE2

PGH Synthase
PGH synthase exists in two isozymes:
-
COX-1
- Constitutively-expressed in most tissues
- NSAIDS such as aspirin, indomethacin, and ibuprofen irreversibly inhibit COX-1
- Action on all tissues leads to side-effects
-
COX-2
- Induced by cytokines in cells associated with the inflammatory response
- Celecoxcib (Celebrex) selectively inhibit COX-2
- Liked to adverse cardiovascular events thought to be linked to PGI2 inhibition
- Aspirin is a reversible inhibitor of COX-2
TXA2
(Thromboxane A2)
- Produced by COX-1 primarily in platelets
- Promotes platelet aggregation
- Vasoconstriction
- Mobilizes intracellular calcium
- Selective contraction or relaxation of smooth muscle

PGI2 (Prostacyclin)
- Produced by COX-2 primarily in endothelium of vessels
- Vasodilation
- Inhibits platelet aggregation
PGE2
(Prostaglandin E2)
- Produced by most tissues, espcially kidney
- Vasodilation
- Relaxes smooth muscle
- Relaxes cervix & contracts uterus inducing labor
- Required for fever response
- Maintains patent ductus arteriosis

PGF2α
(Prostaglandin 2α)
- Produced by most tissues
- Vasoconstriction
- Contraction of smooth muscle
- Stimulates uterine contractions
- Used to induce labor
Aspirin
- Irreversible inhibitor of COX-1
- Platelets anucleated and incapable of synthesizing new COX-1
- Effects are more or less platelet specific
- Decreases risk of CAD
- Reversible inhibitor of COX-2
TXA2 and PGI2
Actions
- TXA2 synthesized by platelets and triggers platelet aggregation.
- PGI2 synthesized by endothelial cells and inhibits platelet aggregation and vasodilation.
- Opposing actions limit platelet aggregation to the site of vascular injury while preventing it downstream of the injury.

Leukotriene Synthesis
Some tissues contain the enzyme 5-lipoxygenase (5-LOX) instead of COX.
-
Arachidonic acid is converted to 5-hydroperoxyeicosatranoic acid (5-HPETE) then to leukotriene A4 (LTA4)
- Non-cyclical molecule
- LTA4 is then converted to:
- Leukotrienes (LTC4, LTD4 LTE4) which contain a conjugated cysteine residue from glutathione
- Termed cysteinyl leukotrienes in mast cells and eosinophils.
- Form the slow-reacting substance of anaphylaxis (SRS-4)
- Mediate allergic and asthmatic responses.
- Act through GPCRs
- Inhibitors of 5-LOX and antagonists of CysLT1 receptors used for asthma prophylaxis.
-
LTB4 in neutrophils and monocytes
- Induces activation and adhesion of leukocytes on endothelium
- Acts as chemoattractant for neutrophils to areas of tissue damage
- Leukotrienes (LTC4, LTD4 LTE4) which contain a conjugated cysteine residue from glutathione
